Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ligand Binding Sites02:40

Ligand Binding Sites

12.7K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.7K
Protein-protein Interfaces02:04

Protein-protein Interfaces

12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K
The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

12.8K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
12.8K
Protein Networks02:26

Protein Networks

3.9K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.9K
Conserved Binding Sites01:49

Conserved Binding Sites

4.2K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.2K
Protein-Drug Binding: Determination Methods01:22

Protein-Drug Binding: Determination Methods

120
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
120

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Selective killing of ALT-cancer cells by Withaferin-A involves destabilization of Rad51 and disruption of DNA repair.

Cell death & disease·2026
Same author

Molecular insights into the anti-COVID-19 activity of reduced (quinol) and oxidized (quinone) forms of coenzyme Q10.

Naunyn-Schmiedeberg's archives of pharmacology·2026
Same author

Conformational changes induced by K949A mutation in the CRISPR-Cas12a complex drives an effective target-binding mechanism.

Current research in structural biology·2025
Same author

Author Correction: Mapping genetic diversity with the GenomeIndia project.

Nature genetics·2025
Same author

Mapping genetic diversity with the GenomeIndia project.

Nature genetics·2025
Same author

Construction and characterization of cloning vector and temperature sensitive vectors for Gordonia sp. IITR100.

Gene·2025

Related Experiment Video

Updated: Jun 6, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.3K

Estimating protein-ligand interactions with geometric deep learning and mixture density models.

Yogesh Kalakoti1, Swaraj Gawande, Durai Sundar

  • 1Department of Biochemical Engineering and Biotechnology, Indian Institute of Technology (IIT) Delhi, New Delhi 110016, India.

Journal of Biosciences
|December 2, 2024
PubMed
Summary

A new deep learning method predicts ligand-protein binding conformations using graph neural networks. This artificial intelligence approach improves structure-based drug design by learning statistical potentials for enhanced molecular optimization.

More Related Videos

Author Spotlight: Exploring Cellular Processes by Modeling Ligands in Cryo-EM Maps
09:30

Author Spotlight: Exploring Cellular Processes by Modeling Ligands in Cryo-EM Maps

Published on: July 19, 2024

1.2K
Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
06:50

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

Published on: January 26, 2024

1.7K

Related Experiment Videos

Last Updated: Jun 6, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.3K
Author Spotlight: Exploring Cellular Processes by Modeling Ligands in Cryo-EM Maps
09:30

Author Spotlight: Exploring Cellular Processes by Modeling Ligands in Cryo-EM Maps

Published on: July 19, 2024

1.2K
Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
06:50

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

Published on: January 26, 2024

1.7K

Area of Science:

  • Computational chemistry
  • Structural biology
  • Artificial intelligence in drug discovery

Background:

  • Understanding ligand-target interactions is vital for drug design.
  • Existing computational methods for predicting binding conformations have limitations.
  • Large structural datasets necessitate advanced statistical frameworks.

Purpose of the Study:

  • To develop a novel computational method for predicting ligand-protein binding conformations.
  • To leverage geometric deep learning for improved drug design workflows.
  • To create a statistical potential tailored for specific ligand-target pairs.

Main Methods:

  • Developed a geometric deep learning framework using graph neural networks.
  • Created graphical representations of proteins to capture binding region properties.
  • Trained a statistical potential based on distance likelihood for each ligand-target pair.
  • Coupled the potential with global optimization algorithms like differential evolution.

Main Results:

  • The method accurately predicts experimental binding conformations of ligands.
  • The learned statistical potential performs comparably to or better than established scoring functions.
  • Demonstrated effectiveness in docking and screening tasks.
  • Showcased the utility of AI in structure-based drug design.

Conclusions:

  • The proposed deep learning method offers a powerful new tool for structure-based drug design.
  • This approach enhances the prediction of ligand-protein binding, aiding molecular optimization.
  • Artificial intelligence can significantly improve computational drug discovery workflows.